AstraZeneca's #COVID19 vaccine (manufactured and administered in India as #Covishield) raised the risk of heart problem, and death by 3.5 times in young women in the first three months following the first dose, according to a report.
Read: https://t.co/oX51vEWouK pic.twitter.com/fSkTmt1Lqp— IANS (@ians_india) March 30, 2023
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


